vs
Side-by-side financial comparison of Clearwater Paper Corp (CLW) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $360.3M, roughly 1.7× Clearwater Paper Corp). Royalty Pharma plc runs the higher net margin — 34.4% vs -3.6%, a 38.0% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -4.7%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 2.3%).
Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
CLW vs RPRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.3M | $622.0M |
| Net Profit | $-12.8M | $214.2M |
| Gross Margin | -0.2% | — |
| Operating Margin | — | 62.4% |
| Net Margin | -3.6% | 34.4% |
| Revenue YoY | -4.7% | 4.8% |
| Net Profit YoY | -103.2% | 2.9% |
| EPS (diluted) | — | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $360.3M | — | ||
| Q4 25 | $386.4M | $622.0M | ||
| Q3 25 | $399.0M | $609.3M | ||
| Q2 25 | $391.8M | $578.7M | ||
| Q1 25 | $378.2M | $568.2M | ||
| Q4 24 | $387.1M | $593.6M | ||
| Q3 24 | $393.3M | $564.7M | ||
| Q2 24 | $344.4M | $537.3M |
| Q1 26 | $-12.8M | — | ||
| Q4 25 | $38.3M | $214.2M | ||
| Q3 25 | $-53.3M | $288.2M | ||
| Q2 25 | $2.7M | $30.2M | ||
| Q1 25 | $-6.3M | $238.3M | ||
| Q4 24 | $199.1M | $208.2M | ||
| Q3 24 | $5.8M | $544.0M | ||
| Q2 24 | $-25.8M | $102.0M |
| Q1 26 | -0.2% | — | ||
| Q4 25 | 4.5% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | -0.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 62.4% | ||
| Q3 25 | -13.9% | 70.1% | ||
| Q2 25 | 2.5% | 36.3% | ||
| Q1 25 | -1.1% | 94.0% | ||
| Q4 24 | -4.0% | 60.9% | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | -13.6% | 50.2% |
| Q1 26 | -3.6% | — | ||
| Q4 25 | 9.9% | 34.4% | ||
| Q3 25 | -13.4% | 47.3% | ||
| Q2 25 | 0.7% | 5.2% | ||
| Q1 25 | -1.7% | 41.9% | ||
| Q4 24 | 51.4% | 35.1% | ||
| Q3 24 | 1.5% | 96.3% | ||
| Q2 24 | -7.5% | 19.0% |
| Q1 26 | — | — | ||
| Q4 25 | $2.36 | $0.49 | ||
| Q3 25 | $-3.30 | $0.67 | ||
| Q2 25 | $0.17 | $0.07 | ||
| Q1 25 | $-0.38 | $0.55 | ||
| Q4 24 | $11.87 | $0.46 | ||
| Q3 24 | $0.35 | $1.21 | ||
| Q2 24 | $-1.55 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.5M | $618.7M |
| Total DebtLower is stronger | $361.1M | $9.0B |
| Stockholders' EquityBook value | $813.8M | $9.7B |
| Total Assets | $1.6B | $19.6B |
| Debt / EquityLower = less leverage | 0.44× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $36.5M | — | ||
| Q4 25 | $30.7M | $618.7M | ||
| Q3 25 | $34.4M | $938.9M | ||
| Q2 25 | $46.7M | $631.9M | ||
| Q1 25 | $44.0M | $1.1B | ||
| Q4 24 | $79.6M | $929.0M | ||
| Q3 24 | $35.5M | $950.1M | ||
| Q2 24 | $39.6M | $1.8B |
| Q1 26 | $361.1M | — | ||
| Q4 25 | $346.8M | $9.0B | ||
| Q3 25 | $337.0M | $8.9B | ||
| Q2 25 | $330.1M | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $283.4M | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $1.1B | $7.6B |
| Q1 26 | $813.8M | — | ||
| Q4 25 | $825.3M | $9.7B | ||
| Q3 25 | $783.0M | $9.6B | ||
| Q2 25 | $836.8M | $9.5B | ||
| Q1 25 | $836.6M | $9.8B | ||
| Q4 24 | $854.6M | $10.3B | ||
| Q3 24 | $664.6M | $10.3B | ||
| Q2 24 | $658.6M | $9.8B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.6B | $19.3B | ||
| Q2 25 | $1.6B | $18.3B | ||
| Q1 25 | $1.6B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | $2.5B | $18.0B | ||
| Q2 24 | $2.5B | $17.7B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.42× | 0.92× | ||
| Q3 25 | 0.43× | 0.93× | ||
| Q2 25 | 0.39× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.33× | 0.74× | ||
| Q3 24 | 1.73× | 0.74× | ||
| Q2 24 | 1.74× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.0M | $827.1M | ||
| Q3 25 | $34.0M | $702.6M | ||
| Q2 25 | $-28.2M | $364.0M | ||
| Q1 25 | $1.5M | $596.1M | ||
| Q4 24 | $-35.1M | $742.5M | ||
| Q3 24 | $16.2M | $703.6M | ||
| Q2 24 | $21.1M | $658.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-9.9M | — | ||
| Q3 25 | $15.7M | — | ||
| Q2 25 | $-51.1M | — | ||
| Q1 25 | $-31.2M | — | ||
| Q4 24 | $-68.1M | — | ||
| Q3 24 | $-30.8M | — | ||
| Q2 24 | $3.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | -2.6% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -13.0% | — | ||
| Q1 25 | -8.2% | — | ||
| Q4 24 | -17.6% | — | ||
| Q3 24 | -7.8% | — | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.9% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 12.0% | — | ||
| Q2 24 | 5.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.13× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | -10.44× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -0.18× | 3.57× | ||
| Q3 24 | 2.79× | 1.29× | ||
| Q2 24 | — | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLW
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
